通过下一代测序对新型HLA-DQA1*05:65:01:01等位基因的表征
Camil Chiali1, Grégory Gatouillat1, Grégory Salez1
1CHU Reims, Laboratoire D'immunologie, Reims, France.
HLA
|February 20, 2026
概括
一种新的人类白细胞抗原 (HLA) 变异,HLA-DQA1*05:65:01:01,已经被确定. 这种新的HLA-DQA1等位基因因与已知的等位基因有单个核酸替代的差异.
科学领域:
- 免疫遗传学 免疫遗传学
- 分子生物学分子生物学
背景情况:
- 人类白细胞抗原 (HLA) 基因对免疫反应至关重要.
- 在HLA基因中的等位基因变异可以影响免疫系统功能和疾病易感性.
研究的目的:
- 为了描述新发现的HLA-DQA1等位基因.
- 描述这个新型等位基因与以前已知的等位基因之间的分子差异.
主要方法:
- 在HLA-DQA1基因的核酸测序.
- 对DNA序列进行比较分析.
主要成果:
- 一个新的等位基因,HLA-DQA1*05:65:01:01被确定.
- 这种新等位基因因与HLA-DQA1*05:05:01:02的区别在于,在4号外基因中,在218号代号的单个核酸替代.
结论:
- 识别新的HLA基因组扩大了我们对HLA多态性的理解.
- 这种变异对于种群遗传学和移植免疫学来说很重要.
关键词:
HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1*05:65 HLA-DQA1哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈这是下一代测序.一个新型的等位基因更多相关视频
08:07Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
10.7K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12.3K
相关概念视频
Next-generation Sequencing
99.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.2K
Genome-wide Association Studies-GWAS
15.8K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.8K
